Research Portal

All Wales Medicines Strategy Group Final Appraisal Report - Icatibant (Firazyr) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency).

Research output: Book/Report › Commissioned report

  • D. Hughes
  • D.A. Hughes
  • [No Value] All Wales Strategy Group.
Original languageEnglish
PublisherUnknown
Commissioning bodyNHS Wales
Edition2008
Publication statusPublished - 1 Jan 2008
View graph of relations